Search - tctmd.com

Displaying 701 - 720 of 7606

Sort: Relevancy | Date

Presentation TCT 2024

TCT 216: Novel Artificial Intelligence Method Reveals Impact Mechanisms From Anatomy via Prosthesis Deformation to Hemodynamics in TAVR Patients

Presenter: Moyang Wang

October 27, 2024

Presentation TCT 2024

TCT 215: Novel Application of 3D Convolutional Neural Networks for Predicting Constrictive Pericarditis Using Routine Coronary Angiograms

Presenter: Shih Sheng Chang

October 27, 2024

Presentation TCT 2024

TCT 214: Patient-Specific Computer Simulation to Predict Transcatheter Heart Valve Eccentricity in Bicuspid Aortic Valve

Presenter: James Dargan

October 27, 2024

Presentation TCT 2024

TCT 213: Validation Study of Digital Twin Based Pre- and Post-TAVR Hemodynamics Analysis

Presenter: Stefan Toggweiler

October 27, 2024

Presentation TCT 2024

TCT 211: Towards Standardizing and Democratizing Mitral Transcatheter Edge-to-Edge Repair With Deep Learning Algorithm

Presenter: Quentin Chatelain

October 27, 2024

Presentation TCT 2024

TCT 188: Inpatient Outcomes of Transcatheter Aortic Valve Replacement Patients on Chronic Anticoagulation: A Nationwide Analysis

Presenter: Ibrahim Kamel

October 27, 2024

Presentation TCT 2024

TCT 187: Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis

Presenter: Tayyab Shah

October 27, 2024

Presentation TCT 2024

TCT 185: Clinical Outcomes of SGLT2 Inhibitors Among Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair

Presenter: Samarthkumar Thakkar

October 27, 2024

Presentation TCT 2024

TCT 184: Comparative Outcomes of SGLT-2 Inhibitors in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Ambica Nair

October 27, 2024

Presentation TCT 2024

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Presenter: Wilbert Bor

October 27, 2024

Presentation TCT 2024

TCT 182: Impact of Heparin-Induced Thrombocytopenia (HIT) on Outcomes in TAVR Patients: A Comprehensive Analysis

Presenter: Neethi Dasu

October 27, 2024

Presentation TCT 2024

How to Recognize Amyloidosis and the Consequences of the Disease?

Presenter: Joban Vaishnav

October 27, 2024

Presentation TCT 2024

TCT 615: Restenosis, Procedural Success and Long-Term Outcomes After Percutaneous Mitral Balloon Commissurotomy in Rheumatic Mitral Disease: Large Single Center Experience

Presenter: Rafael Meneguz-Moreno

October 27, 2024

Presentation TCT 2024

TCT 614: Clinical Characteristics and Prognosis of Patients With Mitral Annular Calcification

Presenter: Gustavo Mendez Hirata

October 27, 2024

Presentation TCT 2024

TCT 613: Mitral Valve Dysfunction in Patients With Mitral Annular Calcification

Presenter: Gustavo Mendez Hirata

October 27, 2024

Presentation TCT 2024

TCT 612: Clinical Outcomes of Patients Anatomically Unsuitable for Transcatheter Mitral Valve Replacement

Presenter: Yuchao Guo

October 27, 2024

Presentation TCT 2024

TCT 610: Temporal Trends in Degenerative Mitral Valve Disease-related Mortality in the United States Over the Past 30 Years

Presenter: Zaid Abdulelah

October 27, 2024

Presentation TCT 2024

TCT 609: Mortality Trends Due to Non-Rheumatic Valvular Disease Among Adults in the United States From Year 1999-2020: CDC WONDER Database Survey Analysis

Presenter: Mobeen Haider

October 27, 2024

Presentation TCT 2024

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

Presenter: Stanislav Fanta

October 27, 2024

Presentation TCT 2024

TCT 148: 30-Day Readmission After Transcatheter Aortic Valve Replacement in Patients With Peripheral Artery Disease

Presenter: Nameer Ascandar

October 27, 2024

Advertisement

TCT 216: Novel Artificial Intelligence Method Reveals Impact Mechanisms From Anatomy via Prosthesis Deformation to Hemodynamics in TAVR Patients

TCT 215: Novel Application of 3D Convolutional Neural Networks for Predicting Constrictive Pericarditis Using Routine Coronary Angiograms

TCT 214: Patient-Specific Computer Simulation to Predict Transcatheter Heart Valve Eccentricity in Bicuspid Aortic Valve

TCT 213: Validation Study of Digital Twin Based Pre- and Post-TAVR Hemodynamics Analysis

TCT 211: Towards Standardizing and Democratizing Mitral Transcatheter Edge-to-Edge Repair With Deep Learning Algorithm

TCT 188: Inpatient Outcomes of Transcatheter Aortic Valve Replacement Patients on Chronic Anticoagulation: A Nationwide Analysis

TCT 187: Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis

TCT 185: Clinical Outcomes of SGLT2 Inhibitors Among Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair

TCT 184: Comparative Outcomes of SGLT-2 Inhibitors in Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

TCT 182: Impact of Heparin-Induced Thrombocytopenia (HIT) on Outcomes in TAVR Patients: A Comprehensive Analysis

How to Recognize Amyloidosis and the Consequences of the Disease?

TCT 615: Restenosis, Procedural Success and Long-Term Outcomes After Percutaneous Mitral Balloon Commissurotomy in Rheumatic Mitral Disease: Large Single Center Experience

TCT 614: Clinical Characteristics and Prognosis of Patients With Mitral Annular Calcification

TCT 613: Mitral Valve Dysfunction in Patients With Mitral Annular Calcification

TCT 612: Clinical Outcomes of Patients Anatomically Unsuitable for Transcatheter Mitral Valve Replacement

TCT 610: Temporal Trends in Degenerative Mitral Valve Disease-related Mortality in the United States Over the Past 30 Years

TCT 609: Mortality Trends Due to Non-Rheumatic Valvular Disease Among Adults in the United States From Year 1999-2020: CDC WONDER Database Survey Analysis

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

TCT 148: 30-Day Readmission After Transcatheter Aortic Valve Replacement in Patients With Peripheral Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content